Elution of gentamicin and vancomycin from polymethylmethacrylate beads and hip spacers in vivo

Background and purpose Late infections after total hip arthroplasty are still a problem. Treatment procedures include resection arthroplasty with implantation of antibiotic-loaded beads or implantation of an antibiotic-impreganted spacer. However, little is known about antibiotic elution from bone c...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Acta orthopaedica 2009-01, Vol.80 (2), p.193-197
Hauptverfasser: Anagnostakos, Konstantinos, Wilmes, Philippe, Schmitt, Eduard, Kelm, Jens
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 197
container_issue 2
container_start_page 193
container_title Acta orthopaedica
container_volume 80
creator Anagnostakos, Konstantinos
Wilmes, Philippe
Schmitt, Eduard
Kelm, Jens
description Background and purpose Late infections after total hip arthroplasty are still a problem. Treatment procedures include resection arthroplasty with implantation of antibiotic-loaded beads or implantation of an antibiotic-impreganted spacer. However, little is known about antibiotic elution from bone cement beyond the first 2-3 postoperative days in humans. Methods 17 hip spacers (80g PMMA, 1g gentamicin, and 4 g vancomycin) and 11 chains (40 g PMMA, 0.5 g gentamicin, and 2 g vancomycin) in 28 patients were studied. The release of both agents was measured in the drainage fluid on a daily basis. The drains were left in situ until less than 50 mL was produced per day. The elution of both antibiotics was determined by fluorescence polarization immunoassay. Systemic antibiotics were given postoperatively according to antibiogram. If possible, no gentamicin or vancomycin was given. Results Peak mean concentrations from beads and spacers were reached for gentamicin (1,160 (12-371) µg/mL and 21 (0.7-39) µg/mL, respectively) and for vancomycin (80 (21-198) µg/mL and 37 (3.3-72) µg/mL) on day 1. The last concentrations to be determined were 3.7 µg/mL gentamicin and 23 µg/mL vancomycin in the beads group after 13 days, and 1.9 µg/mL gentamicin and 6.6 µg/mL vancomycin in the spacer group after 7 days. Between the fifth and seventh day, an intermittent increase in elution of vancomycin from both beads and spacers and of gentamicin from spacers was noticed. No renal or hepatic dysfunction was observed. Interpretation Beads showed higher elution characteristics in vivo than the spacers due to their larger surface area; however, a great amount of inter-subject variability was seen for both beads and spacers. The inferior elution properties of spacers emphasize the importance of additional systemic antibiotics for this treatment procedure during the postoperative period. Future studies should clarify whether the dose of antibiotics or length of antibiotic therapy may be reduced in the case of bead implantation, without jeopardizing the control of infection.
doi_str_mv 10.3109/17453670902884700
format Article
fullrecord <record><control><sourceid>informahealthcare_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2823164</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_3109_17453670902884700</sourcerecordid><originalsourceid>FETCH-LOGICAL-c555t-fa457a08fff179dd051ed7126faef4e4441dad0d64fe7bf7074747464abd75613</originalsourceid><addsrcrecordid>eNp9kF1L5DAUhoMozqy7P8CbpTdezm7SnjYtK4KI-wGCN3prOJMPmyFtStIZ6b-33RnHHRYkkJwk7_Mm5yXknNFvGaPVd8YhzwpOK5qWJXBKj8h8OltkRZke72sOM_IpxhWlWQkVPSUzVgGFkqZz8nTr1r31beJN8qzbHhsrbZtgq5INttI3w7Q1wTdJ593Q6L4e3DSjDIPDXidLjSr-BWrbJbFDqUNMRmhjN_4zOTHoov6yW8_I48_bh5vfi7v7X39uru8WMs_zfmEQco60NMYwXilFc6YVZ2lhUBvQAMAUKqoKMJovDaccplEALhXPC5adkautb7deNlrJsZOATnTBNhgG4dGKw5vW1uLZb0RaphkrYDRgWwMZfIxBmz3LqJjCFv-FPTJf_330ndilOwoudgKMEp0JY6I27nUpg4wBm4wutzrbGh8afPHBKdHj4Hx4g7KP_vHjAK81ur6WGLRY-XVox-A_6OIViSCvgg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Elution of gentamicin and vancomycin from polymethylmethacrylate beads and hip spacers in vivo</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Anagnostakos, Konstantinos ; Wilmes, Philippe ; Schmitt, Eduard ; Kelm, Jens</creator><creatorcontrib>Anagnostakos, Konstantinos ; Wilmes, Philippe ; Schmitt, Eduard ; Kelm, Jens</creatorcontrib><description>Background and purpose Late infections after total hip arthroplasty are still a problem. Treatment procedures include resection arthroplasty with implantation of antibiotic-loaded beads or implantation of an antibiotic-impreganted spacer. However, little is known about antibiotic elution from bone cement beyond the first 2-3 postoperative days in humans. Methods 17 hip spacers (80g PMMA, 1g gentamicin, and 4 g vancomycin) and 11 chains (40 g PMMA, 0.5 g gentamicin, and 2 g vancomycin) in 28 patients were studied. The release of both agents was measured in the drainage fluid on a daily basis. The drains were left in situ until less than 50 mL was produced per day. The elution of both antibiotics was determined by fluorescence polarization immunoassay. Systemic antibiotics were given postoperatively according to antibiogram. If possible, no gentamicin or vancomycin was given. Results Peak mean concentrations from beads and spacers were reached for gentamicin (1,160 (12-371) µg/mL and 21 (0.7-39) µg/mL, respectively) and for vancomycin (80 (21-198) µg/mL and 37 (3.3-72) µg/mL) on day 1. The last concentrations to be determined were 3.7 µg/mL gentamicin and 23 µg/mL vancomycin in the beads group after 13 days, and 1.9 µg/mL gentamicin and 6.6 µg/mL vancomycin in the spacer group after 7 days. Between the fifth and seventh day, an intermittent increase in elution of vancomycin from both beads and spacers and of gentamicin from spacers was noticed. No renal or hepatic dysfunction was observed. Interpretation Beads showed higher elution characteristics in vivo than the spacers due to their larger surface area; however, a great amount of inter-subject variability was seen for both beads and spacers. The inferior elution properties of spacers emphasize the importance of additional systemic antibiotics for this treatment procedure during the postoperative period. Future studies should clarify whether the dose of antibiotics or length of antibiotic therapy may be reduced in the case of bead implantation, without jeopardizing the control of infection.</description><identifier>ISSN: 1745-3674</identifier><identifier>EISSN: 1745-3682</identifier><identifier>DOI: 10.3109/17453670902884700</identifier><identifier>PMID: 19404802</identifier><language>eng</language><publisher>Basingstoke: Informa UK Ltd</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Anti-Bacterial Agents - adverse effects ; Anti-Bacterial Agents - pharmacokinetics ; Antibacterial agents ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Arthroplasty, Replacement, Hip - adverse effects ; Biological and medical sciences ; Bone Cements ; Diseases of the osteoarticular system ; Female ; Gentamicins - administration &amp; dosage ; Gentamicins - pharmacokinetics ; Humans ; Male ; Medical sciences ; Middle Aged ; Pharmacology. Drug treatments ; Polymethyl Methacrylate ; Prospective Studies ; Prosthesis Failure ; Prosthesis-Related Infections - drug therapy ; Prosthesis-Related Infections - microbiology ; Prosthesis-Related Infections - surgery ; Reoperation ; Time Factors ; Vancomycin - administration &amp; dosage ; Vancomycin - pharmacokinetics</subject><ispartof>Acta orthopaedica, 2009-01, Vol.80 (2), p.193-197</ispartof><rights>2009 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2009</rights><rights>2009 INIST-CNRS</rights><rights>Copyright: © Nordic Orthopedic Federation 2009</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c555t-fa457a08fff179dd051ed7126faef4e4441dad0d64fe7bf7074747464abd75613</citedby><cites>FETCH-LOGICAL-c555t-fa457a08fff179dd051ed7126faef4e4441dad0d64fe7bf7074747464abd75613</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2823164/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2823164/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=21431410$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19404802$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Anagnostakos, Konstantinos</creatorcontrib><creatorcontrib>Wilmes, Philippe</creatorcontrib><creatorcontrib>Schmitt, Eduard</creatorcontrib><creatorcontrib>Kelm, Jens</creatorcontrib><title>Elution of gentamicin and vancomycin from polymethylmethacrylate beads and hip spacers in vivo</title><title>Acta orthopaedica</title><addtitle>Acta Orthop</addtitle><description>Background and purpose Late infections after total hip arthroplasty are still a problem. Treatment procedures include resection arthroplasty with implantation of antibiotic-loaded beads or implantation of an antibiotic-impreganted spacer. However, little is known about antibiotic elution from bone cement beyond the first 2-3 postoperative days in humans. Methods 17 hip spacers (80g PMMA, 1g gentamicin, and 4 g vancomycin) and 11 chains (40 g PMMA, 0.5 g gentamicin, and 2 g vancomycin) in 28 patients were studied. The release of both agents was measured in the drainage fluid on a daily basis. The drains were left in situ until less than 50 mL was produced per day. The elution of both antibiotics was determined by fluorescence polarization immunoassay. Systemic antibiotics were given postoperatively according to antibiogram. If possible, no gentamicin or vancomycin was given. Results Peak mean concentrations from beads and spacers were reached for gentamicin (1,160 (12-371) µg/mL and 21 (0.7-39) µg/mL, respectively) and for vancomycin (80 (21-198) µg/mL and 37 (3.3-72) µg/mL) on day 1. The last concentrations to be determined were 3.7 µg/mL gentamicin and 23 µg/mL vancomycin in the beads group after 13 days, and 1.9 µg/mL gentamicin and 6.6 µg/mL vancomycin in the spacer group after 7 days. Between the fifth and seventh day, an intermittent increase in elution of vancomycin from both beads and spacers and of gentamicin from spacers was noticed. No renal or hepatic dysfunction was observed. Interpretation Beads showed higher elution characteristics in vivo than the spacers due to their larger surface area; however, a great amount of inter-subject variability was seen for both beads and spacers. The inferior elution properties of spacers emphasize the importance of additional systemic antibiotics for this treatment procedure during the postoperative period. Future studies should clarify whether the dose of antibiotics or length of antibiotic therapy may be reduced in the case of bead implantation, without jeopardizing the control of infection.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Anti-Bacterial Agents - adverse effects</subject><subject>Anti-Bacterial Agents - pharmacokinetics</subject><subject>Antibacterial agents</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Arthroplasty, Replacement, Hip - adverse effects</subject><subject>Biological and medical sciences</subject><subject>Bone Cements</subject><subject>Diseases of the osteoarticular system</subject><subject>Female</subject><subject>Gentamicins - administration &amp; dosage</subject><subject>Gentamicins - pharmacokinetics</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Pharmacology. Drug treatments</subject><subject>Polymethyl Methacrylate</subject><subject>Prospective Studies</subject><subject>Prosthesis Failure</subject><subject>Prosthesis-Related Infections - drug therapy</subject><subject>Prosthesis-Related Infections - microbiology</subject><subject>Prosthesis-Related Infections - surgery</subject><subject>Reoperation</subject><subject>Time Factors</subject><subject>Vancomycin - administration &amp; dosage</subject><subject>Vancomycin - pharmacokinetics</subject><issn>1745-3674</issn><issn>1745-3682</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kF1L5DAUhoMozqy7P8CbpTdezm7SnjYtK4KI-wGCN3prOJMPmyFtStIZ6b-33RnHHRYkkJwk7_Mm5yXknNFvGaPVd8YhzwpOK5qWJXBKj8h8OltkRZke72sOM_IpxhWlWQkVPSUzVgGFkqZz8nTr1r31beJN8qzbHhsrbZtgq5INttI3w7Q1wTdJ593Q6L4e3DSjDIPDXidLjSr-BWrbJbFDqUNMRmhjN_4zOTHoov6yW8_I48_bh5vfi7v7X39uru8WMs_zfmEQco60NMYwXilFc6YVZ2lhUBvQAMAUKqoKMJovDaccplEALhXPC5adkautb7deNlrJsZOATnTBNhgG4dGKw5vW1uLZb0RaphkrYDRgWwMZfIxBmz3LqJjCFv-FPTJf_330ndilOwoudgKMEp0JY6I27nUpg4wBm4wutzrbGh8afPHBKdHj4Hx4g7KP_vHjAK81ur6WGLRY-XVox-A_6OIViSCvgg</recordid><startdate>20090101</startdate><enddate>20090101</enddate><creator>Anagnostakos, Konstantinos</creator><creator>Wilmes, Philippe</creator><creator>Schmitt, Eduard</creator><creator>Kelm, Jens</creator><general>Informa UK Ltd</general><general>Taylor &amp; Francis</general><general>Informa Healthcare</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20090101</creationdate><title>Elution of gentamicin and vancomycin from polymethylmethacrylate beads and hip spacers in vivo</title><author>Anagnostakos, Konstantinos ; Wilmes, Philippe ; Schmitt, Eduard ; Kelm, Jens</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c555t-fa457a08fff179dd051ed7126faef4e4441dad0d64fe7bf7074747464abd75613</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Anti-Bacterial Agents - adverse effects</topic><topic>Anti-Bacterial Agents - pharmacokinetics</topic><topic>Antibacterial agents</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Arthroplasty, Replacement, Hip - adverse effects</topic><topic>Biological and medical sciences</topic><topic>Bone Cements</topic><topic>Diseases of the osteoarticular system</topic><topic>Female</topic><topic>Gentamicins - administration &amp; dosage</topic><topic>Gentamicins - pharmacokinetics</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Pharmacology. Drug treatments</topic><topic>Polymethyl Methacrylate</topic><topic>Prospective Studies</topic><topic>Prosthesis Failure</topic><topic>Prosthesis-Related Infections - drug therapy</topic><topic>Prosthesis-Related Infections - microbiology</topic><topic>Prosthesis-Related Infections - surgery</topic><topic>Reoperation</topic><topic>Time Factors</topic><topic>Vancomycin - administration &amp; dosage</topic><topic>Vancomycin - pharmacokinetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Anagnostakos, Konstantinos</creatorcontrib><creatorcontrib>Wilmes, Philippe</creatorcontrib><creatorcontrib>Schmitt, Eduard</creatorcontrib><creatorcontrib>Kelm, Jens</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Acta orthopaedica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Anagnostakos, Konstantinos</au><au>Wilmes, Philippe</au><au>Schmitt, Eduard</au><au>Kelm, Jens</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Elution of gentamicin and vancomycin from polymethylmethacrylate beads and hip spacers in vivo</atitle><jtitle>Acta orthopaedica</jtitle><addtitle>Acta Orthop</addtitle><date>2009-01-01</date><risdate>2009</risdate><volume>80</volume><issue>2</issue><spage>193</spage><epage>197</epage><pages>193-197</pages><issn>1745-3674</issn><eissn>1745-3682</eissn><abstract>Background and purpose Late infections after total hip arthroplasty are still a problem. Treatment procedures include resection arthroplasty with implantation of antibiotic-loaded beads or implantation of an antibiotic-impreganted spacer. However, little is known about antibiotic elution from bone cement beyond the first 2-3 postoperative days in humans. Methods 17 hip spacers (80g PMMA, 1g gentamicin, and 4 g vancomycin) and 11 chains (40 g PMMA, 0.5 g gentamicin, and 2 g vancomycin) in 28 patients were studied. The release of both agents was measured in the drainage fluid on a daily basis. The drains were left in situ until less than 50 mL was produced per day. The elution of both antibiotics was determined by fluorescence polarization immunoassay. Systemic antibiotics were given postoperatively according to antibiogram. If possible, no gentamicin or vancomycin was given. Results Peak mean concentrations from beads and spacers were reached for gentamicin (1,160 (12-371) µg/mL and 21 (0.7-39) µg/mL, respectively) and for vancomycin (80 (21-198) µg/mL and 37 (3.3-72) µg/mL) on day 1. The last concentrations to be determined were 3.7 µg/mL gentamicin and 23 µg/mL vancomycin in the beads group after 13 days, and 1.9 µg/mL gentamicin and 6.6 µg/mL vancomycin in the spacer group after 7 days. Between the fifth and seventh day, an intermittent increase in elution of vancomycin from both beads and spacers and of gentamicin from spacers was noticed. No renal or hepatic dysfunction was observed. Interpretation Beads showed higher elution characteristics in vivo than the spacers due to their larger surface area; however, a great amount of inter-subject variability was seen for both beads and spacers. The inferior elution properties of spacers emphasize the importance of additional systemic antibiotics for this treatment procedure during the postoperative period. Future studies should clarify whether the dose of antibiotics or length of antibiotic therapy may be reduced in the case of bead implantation, without jeopardizing the control of infection.</abstract><cop>Basingstoke</cop><pub>Informa UK Ltd</pub><pmid>19404802</pmid><doi>10.3109/17453670902884700</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1745-3674
ispartof Acta orthopaedica, 2009-01, Vol.80 (2), p.193-197
issn 1745-3674
1745-3682
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2823164
source MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection
subjects Adult
Aged
Aged, 80 and over
Anti-Bacterial Agents - adverse effects
Anti-Bacterial Agents - pharmacokinetics
Antibacterial agents
Antibiotics. Antiinfectious agents. Antiparasitic agents
Arthroplasty, Replacement, Hip - adverse effects
Biological and medical sciences
Bone Cements
Diseases of the osteoarticular system
Female
Gentamicins - administration & dosage
Gentamicins - pharmacokinetics
Humans
Male
Medical sciences
Middle Aged
Pharmacology. Drug treatments
Polymethyl Methacrylate
Prospective Studies
Prosthesis Failure
Prosthesis-Related Infections - drug therapy
Prosthesis-Related Infections - microbiology
Prosthesis-Related Infections - surgery
Reoperation
Time Factors
Vancomycin - administration & dosage
Vancomycin - pharmacokinetics
title Elution of gentamicin and vancomycin from polymethylmethacrylate beads and hip spacers in vivo
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T08%3A54%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-informahealthcare_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Elution%20of%20gentamicin%20and%20vancomycin%20from%20polymethylmethacrylate%20beads%20and%20hip%20spacers%20in%20vivo&rft.jtitle=Acta%20orthopaedica&rft.au=Anagnostakos,%20Konstantinos&rft.date=2009-01-01&rft.volume=80&rft.issue=2&rft.spage=193&rft.epage=197&rft.pages=193-197&rft.issn=1745-3674&rft.eissn=1745-3682&rft_id=info:doi/10.3109/17453670902884700&rft_dat=%3Cinformahealthcare_pubme%3E10_3109_17453670902884700%3C/informahealthcare_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/19404802&rfr_iscdi=true